1. Home
  2. ASTS vs NBIX Comparison

ASTS vs NBIX Comparison

Compare ASTS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AST SpaceMobile Inc.

ASTS

AST SpaceMobile Inc.

N/A

Current Price

$57.39

Market Cap

17.5B

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$141.13

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTS
NBIX
Founded
2019
1992
Country
United States
United States
Employees
1126
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5B
15.5B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
ASTS
NBIX
Price
$57.39
$141.13
Analyst Decision
Hold
Strong Buy
Analyst Count
14
28
Target Price
$79.61
★ $208.40
AVG Volume (30 Days)
★ 7.8M
978.0K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.95
EPS
N/A
★ 3.30
Revenue
$4,400,000.00
★ $161,626,000.00
Revenue This Year
$138.08
$36.49
Revenue Next Year
$285.43
$16.51
P/E Ratio
★ N/A
$41.88
Revenue Growth
N/A
★ 977.51
52 Week Low
$49.31
$122.14
52 Week High
$133.86
$186.12

Technical Indicators

Market Signals
Indicator
ASTS
NBIX
Relative Strength Index (RSI) 42.81 38.83
Support Level $54.78 $125.18
Resistance Level $67.20 $142.82
Average True Range (ATR) 3.27 3.63
MACD 0.01 -0.24
Stochastic Oscillator 7.13 27.51

Price Performance

Historical Comparison
ASTS
NBIX

About ASTS AST SpaceMobile Inc.

AST SpaceMobile Inc is currently designing, developing and manufacturing the constellation of BlueBird (BB) satellites and has begun launching its planned space-based Cellular Broadband network distributed through a constellation of low Earth orbit (LEO) satellites. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: